Korompoki Eleni, Ntaios George, Tountopoulou Argyro, Mavraganis Georgios, Tsampalas Evangelos, Kalliontzakis Ioannis, Vassilopoulou Sofia, Manios Efstathios, Savopoulos Christos, Milionis Haralampos, Protogerou Athanasios, Kakaletsis Nikolaos, Galanis Petros, Kaitelidou Daphne, Siskou Olga, Vemmos Konstantinos
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41334 Larissa, Greece.
J Clin Med. 2024 Feb 5;13(3):917. doi: 10.3390/jcm13030917.
The Stroke Units Necessity for Patients (SUN4P) project aims to provide essential data on stroke healthcare in Greece. Herein, we present results on established quality indicators and outcomes after first-ever stroke occurrences.
This prospective multicenter study included consecutive patients admitted to nine hospitals across Greece in 2019-2021. Descriptive statistics were used to present patients' characteristics, key performance measures and stroke outcomes.
Among 892 patients, 755 had ischemic stroke (IS) (mean age 75.6 ± 13.6, 48.7% males) and 137 had hemorrhagic stroke (HS) (mean age 75.8 ± 13.2, 57.7% males). Of those, 15.4% of IS and 8% of HS patients were treated in the acute stroke unit (ASU) and 20.7% and 33.8% were admitted to the intensive care unit (ICU) or high-dependency unit (HDU), respectively. A total of 35 (4.6%) out of 125 eligible patients received intravenous alteplase with a door-to needle time of 60 min (21-90). The time to first scan for IS patients was 60 min (31-105) with 53.2% undergoing a CT scan within 60 min post presentation. Furthermore, 94.4% were discharged on antiplatelets, 69.8% on lipid-lowering therapy and 61.6% on antihypertensives. Oral anticoagulants (OAC) were initiated in 73.2% of the 153 IS patients with atrial fibrillation (AF). Among the 687 IS patients who survived, 85.4% were discharged home, 12% were transferred to rehabilitation centers, 1.2% to nursing homes and 1.3% to another hospital.
The SUN4P Registry is the first study to provide data from a prospectively collected cohort of consecutive patients from nine representative national hospitals. It represents an important step in the evaluation and improvement of the quality of acute stroke care in Greece.
卒中患者卒中单元必要性(SUN4P)项目旨在提供希腊卒中医疗保健的基本数据。在此,我们展示首次发生卒中后的既定质量指标和结果。
这项前瞻性多中心研究纳入了2019年至2021年期间希腊9家医院连续收治的患者。采用描述性统计来呈现患者特征、关键绩效指标和卒中结局。
在892例患者中,755例为缺血性卒中(IS)(平均年龄75.6±13.6岁,男性占48.7%),137例为出血性卒中(HS)(平均年龄75.8±13.2岁,男性占57.7%)。其中,15.4%的IS患者和8%的HS患者在急性卒中单元(ASU)接受治疗,分别有20.7%和33.8%的患者被收入重症监护病房(ICU)或高依赖病房(HDU)。125例符合条件的患者中,共有35例(4.6%)接受了静脉注射阿替普酶治疗,门到针时间为60分钟(21 - 90分钟)。IS患者首次扫描时间为60分钟(31 - 105分钟),53.2%的患者在就诊后60分钟内接受了CT扫描。此外,94.4%的患者出院时服用抗血小板药物,69.8%接受降脂治疗,61.6%接受降压治疗。153例伴有心房颤动(AF)的IS患者中,73.2%开始使用口服抗凝剂(OAC)。在687例存活的IS患者中,85.4%出院回家,12%被转至康复中心,1.2%转至养老院,1.3%转至另一家医院。
SUN4P注册研究是第一项提供来自9家具有代表性的国立医院连续前瞻性收集队列数据的研究。它是评估和改善希腊急性卒中护理质量的重要一步。